Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy.

Clinical Pharmacokinetics
Prajakta S BadriRajeev M Menon

Abstract

The development of direct-acting antiviral (DAA) agents has reinvigorated the treatment of hepatitis C virus infection. The availability of multiple DAA agents and drug combinations has enabled the transition to interferon-free therapy that is applicable to a broad range of patients. However, these DAA combinations are not without drug-drug interactions (DDIs). As every possible DDI permutation cannot be evaluated in a clinical study, guidance is needed for healthcare providers to avoid or minimize drug interaction risk. In this review, we evaluated the DDI potential of the novel three-DAA combination of ombitasvir, paritaprevir, ritonavir, and dasabuvir (the 3D regimen) with more than 200 drugs representing 19 therapeutic drug classes. Outcomes of these DDI studies were compared with the metabolism and elimination routes of prospective concomitant medications to develop mechanism-based and drug-specific guidance on interaction potential. This analysis revealed that the 3D regimen is compatible with many of the drugs that are commonly prescribed to patients with hepatitis C virus infection. Where interaction is possible, risk can be mitigated by paying careful attention to concomitant medications, adjusting drug dosage as neede...Continue Reading

References

Oct 1, 1991·Clinical Pharmacology and Therapeutics·P A SoonsD D Breimer
Nov 1, 1990·Journal of Pharmaceutical Sciences·S M SinghviR A Morrison
Jan 1, 1988·British Journal of Clinical Pharmacology·S M SinghviM Frantz
Oct 1, 1985·Journal of Pharmaceutical Sciences·S ToonR A O'Reilly
Jan 14, 1984·Lancet
Jan 1, 1995·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·C GalliC R Sirtori
Jun 1, 1993·Journal of Clinical Pharmacy and Therapeutics·P BourgetR Roiron
Jan 1, 1996·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·J SchaanningG Bratten
Jan 1, 1997·European Journal of Clinical Pharmacology·T S TracyK R Korzekwa
Jan 1, 1997·European Journal of Clinical Pharmacology·S KudoM Odomi
Nov 3, 1998·Clinical Pharmacology and Therapeutics·D OuelletJ M Leonard
Jan 3, 2001·British Journal of Clinical Pharmacology·C E OngJ O Miners
Apr 11, 2001·Toxicological Sciences : an Official Journal of the Society of Toxicology·C KingM Braun
Oct 19, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Thomayant PrueksaritanontJiunn H Lin
Jan 11, 2003·Journal of Clinical Pharmacology·Craig R LeeJoyce A Goldstein
Mar 5, 2004·British Journal of Clinical Pharmacology·Mark R HutchinsonAndrew A Somogyi
Mar 12, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yuichi OzekiKazumi Danjo
Jun 24, 2004·The American Journal of Medicine·Alessandro AntonelliEle Ferrannini
Aug 12, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·J Andrew WilliamsSimon E Ball
Sep 17, 2004·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·K TougouA Nakamura
Mar 23, 2005·Pharmacology & Therapeutics·Tony K L KiangThomas K H Chang
Apr 2, 2005·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M Miura, T Ohkubo
Apr 14, 2005·Annals of the New York Academy of Sciences·Sergio Carmona, Norma Settecase
Apr 22, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Gwendolyn E KuehlJeannette Bigler
Jul 14, 2005·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M MiuraT Ohkubo
Oct 4, 2005·Expert Opinion on Pharmacotherapy·Brian J GatesNeal M Davies
Oct 4, 2005·Clinical Pharmacology and Therapeutics·Lauri I KajosaariJanne T Backman
Nov 1, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Gwendolyn E KuehlJohanna W Lampe
Feb 21, 2006·British Journal of Clinical Pharmacology·Emilio Perucca
May 26, 2006·Antimicrobial Agents and Chemotherapy·Ville-Veikko HynninenKari Laine
Aug 8, 2006·Clinical Pharmacology and Therapeutics·Manon J van der LeeDavid M Burger
Nov 1, 2006·The European Respiratory Journal·H DerendorfW Wurst
Apr 14, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Marjo VolotinenOlavi Pelkonen
Jan 1, 2008·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Chinam Niranjan PatraMeduri Vimala Devi
Feb 23, 2008·Anesthesiology·Rheem A TotahEvan D Kharasch

❮ Previous
Next ❯

Citations

Jul 29, 2016·The Annals of Pharmacotherapy·Douglas D DeCarolisThomas S Rector
Mar 7, 2017·Clinical Pharmacology in Drug Development·Jennifer R King, Rajeev M Menon
Apr 26, 2017·Expert Opinion on Drug Discovery·Mohamed El KassasGamal Esmat
Oct 11, 2017·Journal of Gastroenterology and Hepatology·Elena González-ColominasJose A Carrión
Oct 16, 2015·Antimicrobial Agents and Chemotherapy·Prajakta S BadriRajeev M Menon
Sep 20, 2018·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Su Nwe SanHarumi Yamada
Jan 27, 2019·Therapeutic Delivery·Gizem BorAnan Yaghmur
Feb 18, 2016·Nature Reviews. Gastroenterology & Hepatology·Jacob A Langness, Gregory T Everson
Mar 5, 2017·Clinical Pharmacokinetics·Jennifer R KingRajeev M Menon
Feb 24, 2017·Clinical Pharmacokinetics·Prajakta S BadriRajeev M Menon
Feb 27, 2017·Clinical Pharmacokinetics·Rajeev M MenonSandeep Dutta

❮ Previous
Next ❯

Methods Mentioned

BETA
sedation
contraception

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.